321 related articles for article (PubMed ID: 27729568)
1. Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia.
Pion SD; Montavon C; Chesnais CB; Kamgno J; Wanji S; Klion AD; Nutman TB; Boussinesq M
Am J Trop Med Hyg; 2016 Dec; 95(6):1417-1423. PubMed ID: 27729568
[TBL] [Abstract][Full Text] [Related]
2. Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region.
Wanji S; Amvongo-Adjia N; Koudou B; Njouendou AJ; Chounna Ndongmo PW; Kengne-Ouafo JA; Datchoua-Poutcheu FR; Fovennso BA; Tayong DB; Fombad FF; Fischer PU; Enyong PI; Bockarie M
PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004184. PubMed ID: 26544042
[TBL] [Abstract][Full Text] [Related]
3. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.
Beng AA; Esum ME; Deribe K; Njouendou AJ; Ndongmo PWC; Abong RA; Fru J; Fombad FF; Nchanji GT; Amambo G; Gandjui NTV; Biholong B; Nko'Ayissi G; Mbia P; Akame J; Enyong PI; Reid SD; Tougoue JJ; Zhang Y; Wanji S
BMC Infect Dis; 2020 Apr; 20(1):284. PubMed ID: 32299374
[TBL] [Abstract][Full Text] [Related]
4. Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon.
Wanji S; Esum ME; Njouendou AJ; Mbeng AA; Chounna Ndongmo PW; Abong RA; Fru J; Fombad FF; Nchanji GT; Ngongeh G; Ngandjui NV; Enyong PI; Storey H; Curtis KC; Fischer K; Fauver JR; Lew D; Goss CW; Fischer PU
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007192. PubMed ID: 30849120
[TBL] [Abstract][Full Text] [Related]
5. Further evidence of the cross-reactivity of the Binax NOW® Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi.
Wanji S; Amvongo-Adjia N; Njouendou AJ; Kengne-Ouafo JA; Ndongmo WP; Fombad FF; Koudou B; Enyong PA; Bockarie M
Parasit Vectors; 2016 May; 9():267. PubMed ID: 27151313
[TBL] [Abstract][Full Text] [Related]
6. Using the AD12-ICT rapid-format test to detect Wuchereria bancrofti circulating antigens in comparison to Og4C3-ELISA and nucleopore membrane filtration and microscopy techniques.
El-Moamly AA; El-Sweify MA; Hafez MA
Parasitol Res; 2012 Sep; 111(3):1379-83. PubMed ID: 22392137
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali.
Coulibaly YI; Coulibaly SY; Dolo H; Konate S; Diallo AA; Doumbia SS; Soumaoro L; Coulibaly ME; Dicko I; Sangare MB; Dembele B; Sangare M; Dembele M; Touré YT; Kelly-Hope L; Polman K; Kyelem D; Traore SF; Bockarie M; Klion AD; Nutman TB
Parasit Vectors; 2016 Dec; 9(1):628. PubMed ID: 27912789
[TBL] [Abstract][Full Text] [Related]
8. Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures.
Gounoue-Kamkumo R; Nana-Djeunga HC; Bopda J; Akame J; Tarini A; Kamgno J
BMC Infect Dis; 2015 Dec; 15():579. PubMed ID: 26700472
[TBL] [Abstract][Full Text] [Related]
9. A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.
Chesnais CB; Awaca-Uvon NP; Bolay FK; Boussinesq M; Fischer PU; Gankpala L; Meite A; Missamou F; Pion SD; Weil GJ
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005703. PubMed ID: 28892473
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of Loa loa antigens responsible for cross-reactivity with rapid diagnostic tests for lymphatic filariasis.
Hertz MI; Nana-Djeunga H; Kamgno J; Jelil Njouendou A; Chawa Chunda V; Wanji S; Rush A; Fischer PU; Weil GJ; Budge PJ
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006963. PubMed ID: 30444866
[TBL] [Abstract][Full Text] [Related]
11. Filarial antigenemia and Loa loa night blood microfilaremia in an area without bancroftian filariasis in the Democratic Republic of Congo.
Bakajika DK; Nigo MM; Lotsima JP; Masikini GA; Fischer K; Lloyd MM; Weil GJ; Fischer PU
Am J Trop Med Hyg; 2014 Dec; 91(6):1142-1148. PubMed ID: 25223938
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tests for the detection of circulating filarial antigen (Og4C3-ELISA and AD12-ICT) and ultrasound in diagnosis of lymphatic filariasis in individuals with microfilariae.
Rocha A; Braga C; Belém M; Carrera A; Aguiar-Santos A; Oliveira P; Texeira MJ; Furtado A
Mem Inst Oswaldo Cruz; 2009 Jul; 104(4):621-5. PubMed ID: 19722087
[TBL] [Abstract][Full Text] [Related]
13. Wuchereria bancrofti infection in rural tropical guinea savannah communities: Rapid epidemiological assessment using immunochromatographic card test and prevalence of hydrocoele.
Ivoke N; Ezeabikwa BO; Ivoke ON; Ekeh FN; Ezenwaji NE; Odo GE; Onoja US; Eyo JE
Trop Biomed; 2015 Jun; 32(2):365-75. PubMed ID: 26691265
[TBL] [Abstract][Full Text] [Related]
14. Assessing drivers of the IgG4 antibody reactivity to recombinant antigen Bm14 in Wuchereria bancrofti endemic populations in East Africa.
Damgaard J; Meyrowitsch DW; Rwegoshora RT; Magesa SM; Mukoko DA; Simonsen PE
Acta Trop; 2016 Sep; 161():26-32. PubMed ID: 27172877
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa.
de Souza DK; Owusu IO; Otchere J; Adimazoya M; Frempong K; Ahorlu CS; Boakye DA; Wilson MD
Pan Afr Med J; 2017; 27():65. PubMed ID: 28819487
[TBL] [Abstract][Full Text] [Related]
16. Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review.
Kelly-Hope LA; Hemingway J; Taylor MJ; Molyneux DH
Parasit Vectors; 2018 Jun; 11(1):349. PubMed ID: 29907117
[TBL] [Abstract][Full Text] [Related]
17. Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis.
Steel C; Golden A; Kubofcik J; LaRue N; de Los Santos T; Domingo GJ; Nutman TB
Clin Vaccine Immunol; 2013 Aug; 20(8):1155-61. PubMed ID: 23740923
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a single oral dose of diethylcarbamazine 300 mg as provocative test and simultaneous treatment in Myanmar migrant workers with Wuchereria bancrofti infection in Thailand.
Bhumiratana A; Siriaut C; Koyadun S; Satitvipawee P
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):591-8. PubMed ID: 15689072
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of Haiti.
Hamlin KL; Moss DM; Priest JW; Roberts J; Kubofcik J; Gass K; Streit TG; Nutman TB; Eberhard ML; Lammie PJ
PLoS Negl Trop Dis; 2012; 6(12):e1941. PubMed ID: 23236534
[TBL] [Abstract][Full Text] [Related]
20. A practical strategy for responding to a case of lymphatic filariasis post-elimination in Pacific Islands.
Harrington H; Asugeni J; Jimuru C; Gwalaa J; Ribeyro E; Bradbury R; Joseph H; Melrose W; MacLaren D; Speare R
Parasit Vectors; 2013 Jul; 6():218. PubMed ID: 23890320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
